Dentists in Manchester Ctr, VT Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. Andrew Xavier Schmid Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5053 Main Street, Manchester Ctr, VT 05255 Phone: 802-362-2345 |
 Dr. Catherine Cech, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5271 Main Street, Manchester Ctr, VT 05255 Phone: 802-362-1014 |
News Archive
Asian children and black children experience higher rates of ruptured appendixes than white children
Asian children and black children experience higher rates of ruptured appendixes than white children, as do uninsured or Medicaid-insured children, compared to children covered by private insurance, according to a study in the October 27 issue of JAMA.
Global Fund postpones Round 11 grants, approves new strategy and organization plan
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to postpone Round 11 grant approval during a two-day meeting in Accra, Ghana, that concluded on November 22. According to a press release from the Global Fund, the decision to postpone Round 11 was due to "a revised resource forecast presented to the Board which showed that substantial budget challenges in some donor countries, compounded by low interest rates, have significantly affected the resources available for new grant funding."
Researchers test benefit of 'smart' shoe insole for patients with knee osteoarthritis
Osteoarthritis, in the simplest sense, is wear and tear of the cartilage (connecting tissue) of the joints, which results in bones rubbing together, causing pain and stiffness. While other factors, such as genetics, can affect the progression of osteoarthritis, the less strain a person puts on his or her joints, the less likely the cartilage is to deteriorate.
AMDL submits data to FDA for clearance to market its diagnostic test to monitor colorectal cancer patients
AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.
Scientists discover factors that reduce breast screening effectiveness
Scientists have found evidence that the reduced effectiveness of breast screening in women in their 40s is mainly due to their tumours being harder to detect, rather than because they grow faster.Previous research has suggested that breast screening is less effective in women in their 40s than in older women.Two reasons have been identified for this - firstly, that younger women tend to have denser breast tissue which makes it harder to detect tumours on a mammogram; and secondly, because younger women's tumours tend to grow more quickly.
› Verified 9 days ago